Abstract
Traditional severity criteria of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) were determined retrospectively but found inappropriate for therapeutic decisions. Data of 203 patients with SOS/VOD were collected according to the modified Seattle diagnostic criteria and were analyzed for validation of the revised severity criteria recently proposed from European Society for Blood and Marrow Transplantation (EBMT). According to the traditional severity criteria, none of the patients were mild grade, while 63.1% were moderate and 36.9% were severe grade. However, according to the revised EBMT criteria, the majority of patients (63.1%) were very severe, 18.2% were severe, 12.8% were moderate, and 5.9% were mild grade. The 100-day overall survival (OS) of mild, moderate, severe and very severe groups was 83.3, 84.3, 94.6, and 58.6%, respectively. Very severe SOS/VOD showed a significantly lower OS than the others (58.6 vs. 89.3%, p < 0.0001). The 100-day transplantation-related mortality was 25.2% in the entire cohort; 8.3% in mild, 8.0% in moderate, 2.7% in severe, and 36.7% in very severe SOS/VOD (p < 0.0001). The very severe grade newly classified by the revised EBMT criteria accounted for the majority of SOS/VO...Continue Reading
References
Dec 1, 1987·Transplantation·R J JonesR Saral
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G B McDonaldE D Thomas
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S I BearmanG B McDonald
Feb 15, 1993·Annals of Internal Medicine·G B McDonaldR A Clift
Jun 11, 2003·Bone Marrow Transplantation·D L ForrestR Pierce
Oct 18, 2003·Current Opinion in Hematology·Martha WadleighPaul Richardson
Jul 24, 2008·Bone Marrow Transplantation·M MianoUNKNOWN EBMT Paediatric Working Party
Sep 22, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jason A CoppellDietger Niederwieser
Dec 17, 2009·Bone Marrow Transplantation·S H LeeH S Ahn
Jul 31, 2013·Bone Marrow Transplantation·J-H YoonC-W Park
May 17, 2014·Blood·Nelson Chao
Nov 18, 2014·British Journal of Haematology·Enric Carreras
Mar 24, 2015·Bone Marrow Transplantation·M MohtyE Carreras
Jan 31, 2016·Blood·Paul G RichardsonRobert J Soiffer
May 18, 2016·Bone Marrow Transplantation·M MohtyE Carreras
Mar 13, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul G RichardsonUNKNOWN Defibrotide Study Group
Apr 27, 2017·British Journal of Haematology·Paul G RichardsonRobert J Soiffer
Aug 2, 2017·Bone Marrow Transplantation·S CorbaciogluP Bader
May 17, 2018·British Journal of Haematology·Nancy A KernanPaul Richardson
Citations
Jun 13, 2019·Journal of Clinical Medicine·Natalia MaximovaRoberto Simeone
Oct 3, 2019·Bone Marrow Transplantation·Mohamad MohtyEnric Carreras
Dec 14, 2019·European Journal of Gastroenterology & Hepatology·Chunyan PengYuzheng Zhuge
Jan 29, 2021·Hepatology International·Jiangqiang XiaoYuzheng Zhuge
Aug 14, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ignacio Gómez-CenturiónMi Kwon
Feb 3, 2021·Bone Marrow Transplantation·Jae-Ho YoonSeok Lee
Jul 14, 2021·Journal of Cancer Research and Clinical Oncology·Jaspar KloehnBernd Gruhn
Sep 24, 2021·The Korean Journal of Internal Medicine·Jae-Ho YoonJong-Ho Won